MannKind Corp. CEO Discloses Buying 700K Shares

In a Form 4 filing with the SEC, CEO, 10% Owner of MannKind Corp. (MNKD), discloses buying 700,000 shares of  MNKD on 01/12/2011 at an average price of $8.71 p/sh for a total of $2,800,000.

MannKind Corp has a market cap of $1.12 billion; its shares were trading during Wednesday afternoon trading at around $9.01 with a PEG ratio of (0.10).

Mankind is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer. The co. was founded in 1991 and is based in Valencia, California.

Create Content With AI

Try TradingView For Free

Risk Our Money Not Yours | Get 50% Off Any Account

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

About Ron Haruni 1065 Articles
Ron Haruni is the Co-Founder & Editor in Chief of Wall Street Pit.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.